Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (intron a)

This publication has 16 references indexed in Scilit:

• A radioimmunologic technique to screen for antibodies to α-2 interferon
  Journal of Immunological Methods, 1984
• Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma
  The American Journal of Medicine, 1984
• Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds
  Antimicrobial Agents and Chemotherapy, 1984
• Interferons in the treatment of human cancer.
  Journal of Clinical Oncology, 1984
• A phase I clinical tolerance study of rDNA alpha2 human interferon in patients with non-reticuloendothelial system malignancies
  European Journal of Cancer and Clinical Oncology, 1983
• Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's Sarcoma
  New England Journal of Medicine, 1983
• ANTIBODIES TO HUMAN LEUCOCYTE INTERFERONS IN CANCER PATIENTS
  The Lancet, 1983
• Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients
  Annals of Internal Medicine, 1982
• Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon
  Nature, 1981